Although sarcoidosis of the upper respiratory tract (SURT) is generally considered to be uncommon, SURT occurs more frequently than generally realized, and it can have most persistent and disabling manifestations.1 The lesions due to SURT involve the nose (69%), sinuses (50–64%), tonsils (36%), larynx, (1–5%), and
tongue (rare).3–14To establish the diagnosis,2–10,13,14histo- logical confirmation of the disease is necessary, along with an assessment of the extent and severity of the disease, an assessment of whether the disease is stable or likely to progress, and a determination of the therapy’s benefit is needed.
107
CHAPTER 19
Sarcoidosis of the Upper Respiratory Tract
FIGURE 19.1 A chest X-ray with bilateral hilar lymph nodes enlargement. The diagnosis of pulmonary sarcoidosis was estab- lished in 1999. The patient was treated with corticosteroids. During follow-up visits, he complained of nasal crusting and dryness. His angiotensin converting enzyme (ACE) was high. Biopsy specimen from the nasal mucosa showed granulomatous inflammation.
FIGURE 19.2 Although the lesions resemble the herpes simplex crusts on the nasal mucosa, the biopsy showed noncaseating granulomas.
108 Atlas of Sarcoidosis
Chest X-ray findings, which are the first line of inves- tigation in diagnosing sarcoidosis, are abnormal in more than 90% of patients.
REFERENCES
1. Neville E, Miles R, James D. Sarcoidosis of the upper respi- ratory tract. Ann NY Acad Sci 1976;278:416.
2. Milton CM. Sarcoidosis in ENT practice. Clin Otolaryngol 1985;10:351–355.
3. McCaffrey T, McDonald T. Sarcoidosis of the nose and paranasal sinuses. Laryngoscope 1983;93:1281–1284.
4. Fenton D, Shaw M, Black M. Invasive nasal sarcoidosis treated with methotrexate. Clin Exp Dermatol 1985;10:
279–283.
5. Miao J. A Clinicopathologic analysis of 70 cases of sar- coidosis. Chinese Journal of Tuberculosis and Respiratory Diseases 1989;12:204–253.
6. Devine K. Sarcoidosis of the larynx. Laryngoscope 1965;89:
533–537.
7. Neel H, McDonald T. Laryngeal sarcoidosis. Report of 13 cases. Ann Otol Rhinol Laryngol 1982;91:359–362.
8. Shah R, Mills P, George P, Wedzicha J. Upper airway sarcoidosis presenting as obstructive sleep apnea. Thorax 1998;53:232–233.
9. Bower JS, Belen JE, Weg JG, Dantzker DR. Manifestations and treatment of laryngeal sarcoidosis. Amer Rev Resp Dis 1980;12:325–332.
10. DeSazo R, O’Brien M, Justice W, Pitcock J. Diagnostic cri- teria for sarcoidosis of the sinuses. J Allergy Clin Immunol 1999;103:779–789.
11. Dibenedetto R, Lefrak S. Sistemic sarcoidosis with severe involvement of the upper respiratory tract. Am Rev Resp Dis 1970;102:801.
12. Mendelsohn S, Field E, Woolgar J. Sarcoidosis of the tongue.
Clin Exp Dermatol 1992;17:47–48.
13. Fogel T, Weissberg J, Dobular K, Kirchner J. Radiotherapy in sarcoidosis of the larynx: case report and review of the literature. Laryngoscope 1984;94:1223–1225.
14. Paller A, Surek C, Silva Walsh I, Krespi Y, Freinkel RK. Cuta- neous sarcoidosis associated with sarcoidosis of the upper airway. Arch Dermatol 1983;119:592–596.
FIGURE 19.3 A 58-year-old female patient with chronic sar- coidosis involving lungs, bones, and nails. The biopsy specimen confirmed the diagnosis of the nasal mucosa sarcoidosis. She is under the treatment with methotrexate. Her response to steroids was poor, and she did not tolerate the side effects of the prednisolone.
FIGURE 19.4 Much improved, the same patient shown in Figure 19.3 is still receiving methotrexate.